Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001183740-21-000281
Filing Date
2021-11-03
Accepted
2021-11-03 12:16:55
Documents
3
Period of Report
2021-11-03

Document Format Files

Seq Description Document Type Size
1 f6k-20211103drug.htm 6-K 5445
2 NEWS RELEASE DATED NOVEMBER 3, 2021 ex991-20211103drug.htm EX-99.1 13503
3 ex99120211103drug_1.jpg GRAPHIC 5992
  Complete submission text file 0001183740-21-000281.txt   28336
Mailing Address 1500 - 1055 WEST GEORGIA ST. VANCOUVER A1 V6E 4N7
Business Address 1500 - 1055 WEST GEORGIA ST. VANCOUVER A1 V6E 4N7 6474072515
BRIGHT MINDS BIOSCIENCES INC. (Filer) CIK: 0001827401 (see all company filings)

EIN.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-40997 | Film No.: 211374417
SIC: 2834 Pharmaceutical Preparations